Evidence map›Paper›PMID 33659087›Full record

ReviewBiomedical optics express2021

Applications of augmented reality in ophthalmology [Invited].

Güneş Aydındoğan, Koray Kavaklı, Afsun Şahin, Pablo Artal, Hakan Ürey

Abstract readReview
In one paragraph

Review in Biomedical optics express, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Visual Field Dependence Persists in Age-Related Central Visual Field Loss.Investigative ophthalmology & visual science · 2024
    Article
  12. Article
  13. Rendering algorithms for aberrated human vision simulation.Visual computing for industry, biomedicine, and art · 2023
    Review
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Güneş AydındoğanKoç University, Department of Electrical Engineering and Translational Medicine Research Center (KUTTAM), Istanbul 34450, Turkey.ORCID https://orcid.org/0000-0003-4354-633X
Koray KavaklıKoç University, Department of Electrical Engineering and Translational Medicine Research Center (KUTTAM), Istanbul 34450, Turkey.
Afsun ŞahinKoç University, School of Medicine and Translational Medicine Research Center (KUTTAM), Istanbul 34450, Turkey.
Pablo ArtalLaboratorio de Óptica, Instituto Universitario de Investigación en Óptica y Nanofísica, Universidad de Murcia, Campus de Espinardo, E-30100 Murcia, Spain.ORCID https://orcid.org/0000-0003-1284-6591
Hakan ÜreyKoç University, Department of Electrical Engineering and Translational Medicine Research Center (KUTTAM), Istanbul 34450, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Throughout the last decade, augmented reality (AR) head-mounted displays (HMDs) have gradually become a substantial part of modern life, with increasing applications ranging from gaming and driver assistance to medical training. Owing to the tremendous progress in miniaturized displays, cameras, and sensors, HMDs are now used for the diagnosis, treatment, and follow-up of several eye diseases. In this review, we discuss the current state-of-the-art as well as potential uses of AR in ophthalmology. This review includes the following topics: (i) underlying optical technologies, displays and trackers, holography, and adaptive optics; (ii) accommodation, 3D vision, and related problems such as presbyopia, amblyopia, strabismus, and refractive errors; (iii) AR technologies in lens and corneal disorders, in particular cataract and keratoconus; (iv) AR technologies in retinal disorders including age-related macular degeneration (AMD), glaucoma, color blindness, and vision simulators developed for other types of low-vision patients.

Identifiers

PMID33659087
PMCPMC7899512

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.